Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Hypertens ; 23(7): 802-8, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20360751

RESUMEN

BACKGROUND: In fawn-hooded hypertensive (FHH) rats, a model of hypertension, impaired preglomerular resistance, hyperfiltration, and progressive renal injury, we recently observed that supporting perinatal nitric oxide (NO) availability with the NO donor molsidomine persistently reduced blood pressure (BP) and ameliorated renal injury in male and female offspring. However, beneficial effects of perinatal molsidomine treatment were more pronounced in female than in male FHH rats. METHODS: To evaluate whether such protective effects could also be achieved with micronutrients, and whether the gender-dependent differences could be confirmed, we tested perinatal exposure to the micronutrients L-arginine, taurine, vitamin C, and vitamin E (ATCE) in FHH rats. Perinatal micronutrients increased urinary NO metabolite, sodium and potassium excretion only at 4 weeks of age, i.e., at the end of treatment. RESULTS: From 12 weeks onwards, control males had a significantly higher systolic BP (SBP) than females (P < 0.01); however after perinatal micronutrients, this difference was no longer present, indicating a pronounced antihypertensive effect of perinatal micronutrients in males (interaction P < 0.001). Development of proteinuria was attenuated by perinatal micronutrients in males and females. However, only females showed reduced glomerular filtration rate, filtration fraction, and glomerulosclerosis (GS) after perinatal micronutrients. CONCLUSIONS: In sum, perinatal micronutrients that enhance NO availability ameliorated development of hypertension and proteinuria in FHH rats. Antihypertensive effects were more pronounced in male FHH offspring, whereas renal protective effects were more pronounced in female FHH offspring. Mechanisms underlying gender-specific consequences of perinatal micronutrients require further study.


Asunto(s)
Suplementos Dietéticos , Hipertensión/prevención & control , Enfermedades Renales/prevención & control , Micronutrientes/administración & dosificación , Proteinuria/prevención & control , Animales , Arginina/administración & dosificación , Ácido Ascórbico/administración & dosificación , Presión Sanguínea , Femenino , Hipertensión/complicaciones , Enfermedades Renales/etiología , Enfermedades Renales/patología , Masculino , Molsidomina/administración & dosificación , Ácido Nítrico/metabolismo , Ácido Nítrico/orina , Donantes de Óxido Nítrico/administración & dosificación , Potasio/metabolismo , Potasio/orina , Proteinuria/etiología , Ratas , Ratas Endogámicas , Factores Sexuales , Sodio/metabolismo , Sodio/orina , Taurina/administración & dosificación , Vitamina E/administración & dosificación
2.
Br J Dermatol ; 147(5): 914-9, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12410700

RESUMEN

BACKGROUND: Several laboratory markers have been described to correlate positively with disease activity of atopic dermatitis (AD). These include soluble adhesion molecules and eosinophil granular proteins. Although the correlation of these parameters with the severity and extent of skin involvement has been repeatedly studied in the past, no systematic investigation has been performed over a lengthy period of time. In addition, no subjective disease parameters recorded by the patient have been included in studies dealing with disease activity. OBJECTIVES: To assess the validity of different objective and subjective parameters [soluble E-selectin (sE-selectin), soluble vascular cell adhesion molecule-1 (sVCAM-1), eosinophil cationic protein (ECP), urinary nitrate excretion (reflecting endogenous nitric oxide formation) and the patients' impressions of pruritus, sleeplessness and skin status] as markers of AD disease activity. METHODS: Twenty patients were examined for 1 year and their skin status was evaluated by an established score (SCORAD). sE-selectin, sVCAM-1 and ECP were analysed by commercial test kits. Urinary nitrate concentration was measured by gas chromatography-mass spectrometry. The subjective parameters, pruritus, sleeplessness and impression of skin status, were recorded by the patients on a visual analogue scale. RESULTS: In this long-term trial, only sE-selectin and the subjective parameters showed a statistically significant correlation with the SCORAD score. CONCLUSIONS: Our data indicate that basic clinical scoring remains a most effective and relevant method of recording skin disease activity in AD.


Asunto(s)
Dermatitis Atópica/sangre , Selectina E/sangre , Ribonucleasas , Índice de Severidad de la Enfermedad , Adolescente , Adulto , Biomarcadores/sangre , Proteínas Sanguíneas/metabolismo , Dermatitis Atópica/complicaciones , Dermatitis Atópica/patología , Proteínas en los Gránulos del Eosinófilo , Femenino , Estudios de Seguimiento , Humanos , Masculino , Ácido Nítrico/orina , Prurito/etiología , Trastornos del Sueño-Vigilia/etiología , Molécula 1 de Adhesión Celular Vascular/sangre
3.
Gut ; 45(3): 355-61, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10446102

RESUMEN

BACKGROUND: There is evidence that endogenous nitrate synthesis is notably increased in patients with infective gastroenteritis. AIMS: To determine whether this is due to nitric oxide (NO) production via the L-arginine/NO pathway. METHODS: Seven male patients with community acquired bacterial gastroenteritis and 15 healthy male volunteers participated in this study. All patients had stool culture positive infective gastroenteritis. A bolus of 200 mg L-[(15)N](2)-arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours. Urinary [(15)N:(14)N]nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. RESULTS: Mean 36 hour total urinary nitrate excretion in the gastroenteritis group was 5157 (577) micromol compared with 2594 (234) micromol in the control group (p<0.001). Thirty six hour urinary [(15)N]nitrate excretion was considerably higher in the gastroenteritis group compared with the control group (13782 (1665) versus 1698 (98) etamol; p<0.001). These values represent 1.129 (0.139)% and 0.138 (0.007)% of [(15)N]nitrogen administered (p<0.001), respectively. Corrected 36 hour urinary [(15)N]nitrate excretion for urinary creatinine was also significantly higher in the patient compared with the control group (1934 (221) versus 303 (35) etamol/mmol; p<0.001). CONCLUSION: Results show notably enhanced nitrate synthesis due to increased activity of the L-arginine/NO pathway in patients with infective gastroenteritis.


Asunto(s)
Arginina/metabolismo , Infecciones Bacterianas/metabolismo , Gastroenteritis/metabolismo , Óxido Nítrico/biosíntesis , Adulto , Humanos , Masculino , Ácido Nítrico/orina , Isótopos de Nitrógeno
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA